Psychedelic Research Incubator · Sheri Eckert Foundation

Sheri Eckert Foundation · Psychedelic Research Incubator

Real-world research, built for public benefit.

In 2020, Oregon voters created the world's first state-regulated psychedelic healthcare program. People now receive legal, supervised psilocybin care every week in Oregon and Colorado, and soon in New Mexico. That creates something research has never had: a legal, real-world setting to study what this care actually does, what it costs, and who it reaches.

Because these medicines are naturally occurring or off-patent, commercial sponsors won't fund those studies. So the Sheri Eckert Foundation funds, builds, and deploys them directly, with university and community partners, and we publish everything we learn.

Research is how a state-regulated model earns the trust to spread:

Step 1Real-world evidence

Rigorous studies inside legal programs show safety, outcomes & cost.

Step 2Public trust

Credible results build confidence among the public and policymakers.

Step 3State adoption

More states adopt the model as the evidence and trust grow.

The goalAccess & coverage

Public funding and insurance follow, making care affordable at scale.

Named for Sheri Eckert, who helped create that first program. We carry her work forward.

Choose your path

What would you like to understand?

Everything below opens right here on this page. Close a path any time and pick another.

The standalone tracker · built to share View the full policy tracker

Every state, every bill, the patents, the federal pipeline, and the world, on its own shareable page. The rising tide that started in Oregon, tracked in one place.

Open the standalone tracker

Our flagship study · ORCHID

The evidence that unlocks state-regulated psychedelic healthcare.

ORCHID links real psilocybin care to real medical claims to show whether it lowers health-system costs. Created, organized, and funded by SEF with UC Berkeley and UCSF, Phase 1 ($458K) is raising now.

Thinking about participating in a study?  See what's enrolling now and how to raise your hand.

The Sheri Eckert Foundation is a 501(c)(3) nonprofit project of the Oregon Research Foundation. This page summarizes research and policy for educational purposes; it is not medical or legal advice. Figures are sourced from cited studies and public reporting and are illustrative of scale, not precise forecasts.

July 17–19, 2026 · Fernlove Retreat Center, Gaston, Oregon

We funded the retreat. They chose to help study it.

A legal group psilocybin retreat for about a dozen previously incarcerated people, paid for in full by the Inward Dive Fund, with an observational study most of them opted into. Believed to be the first of its kind with this group. Results are pending.

01 / 07

01 / Organizing it

Getting a dozen people to the door

Most people who could benefit most from legal psilocybin care cannot get near it. The cost is high, it is rarely covered, and a record closes doors that were already narrow.

So the Inward Dive Fund paid for the whole thing: the service center, the facilitators, the lodging and the meals, for a group of previously incarcerated people over three days in the Oregon forest.

About a dozenpreviously incarcerated participants
3 daysFriday arrival to Sunday close
Fully fundedby the Inward Dive Fund
30 acresof forest above Hagg Lake

02 / The weekend

Three days at Fernlove

  • ThursdayTeam preparationFacilitators, researchers and the venue team set up the spaces and walked the flow.
  • FridayArrival and orientationParticipants arrived, settled in, and met the people who would be with them all weekend.
  • Friday and SaturdayTwo journey daysThe group was split across two administration days at a state-licensed service center.
  • SundayIntegration and closingMorning integration, closing activities, then a group shuttle back to Portland.

03 / The choice

The research was optional. Most people said yes.

Nobody had to take part. Opting out changed nothing about who could attend or what they received.

The study is observational only. The researchers did not provide psilocybin, did not administer it, and did not change the retreat. The retreat came first and the research was built to fit around it.

Most participants opted in anyway, which is the reason there is anything to learn from at all.

04 / The study

What it actually measured

  • BeforeBaselineQuestionnaires on stress, anxiety, mood, connection and relationship to nature, a short social perception activity, and noninvasive Muse EEG headband and Polar H10 heart recordings.
  • DuringThe sessionParticipation in their allocated journey day, unchanged by the study.
  • AfterFollow upInterviews, surveys, the social perception exercise again, and a second biometric reading on Sunday.

Nothing invasive: no needles, no blood draws, nothing placed inside the body.

05 / The researchers

Who ran it

Conducted by researchers affiliated with the Center for Collective Healing and Yale University.

Dr. AZA Stephen Allsop, MD, PhD Yale University · Center for Collective Healing, Howard University

Artist, neuroscientist and psychiatrist studying how social information is computed in the brain, and how music, mindfulness and psychedelics may change social connectedness and stress.

Marik Hazan Engineer, advocate, entrepreneur and investor

06 / What we heard

Positive overall, and a list of things to fix

Feedback from participants to the research team was positive overall. That is as far as we can go right now: the study results are still pending, and we are not going to get ahead of them.

We also came away with a clear list of things to do better, from how we screen and prepare people to how the schedule holds the day after.

The second retreat is being planned now. Dates to be announced.

Scroll sideways, drag, or use the arrow keys